UBS Raises PT on Colgate-Palmolive (CL); Hard to Poke Holes in Q2
Tweet Send to a FriendGet Alerts CL Hot Sheet
Price: $61.55 --0%
Rating Summary:
5 Buy, 11 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 6
Rating Summary:
5 Buy, 11 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 6
Trade CL Now!
UBS maintains a 'Neutral' on Colgate-Palmolive Company (NYSE: CL) price target of $104.00 (from $98.00).
Analyst, Nik Modi, said, "We saw an improvement in the quality of Colgate’s results for 2Q’12, and underlying fundamentals showed positive signs despite a sizeable currency impact. We estimate that over 75% of Colgate’s EPS growth this quarter came from operating items (SG&A, gross margins) and share buybacks. Top-line/EBIT growth from Latin America /APAC accounted for 89% and 200% of sales/EBIT growth. While Colgate implicitly lowered "all in" EPS due to FX, you can’t really argue with 8.5% organic revenue growth in this environment."
Modi sees impressive quarters from CL, Kimberly Clark (NYSE: KMB), Unilever (NYSE: UN), Natura and L'Oreal the reverse-Procter-Gamble (NYSE: PG) Effect. However, Modi sees cheaper alternatives in the sector (vs. CL at current level).
For an analyst ratings summary and ratings history on Colgate-Palmolive Company click here. For more ratings news on Colgate-Palmolive Company click here.
Shares of Colgate-Palmolive Company closed at $106.38 yesterday, with a 52 week range of $78.62-$106.83.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Analyst, Nik Modi, said, "We saw an improvement in the quality of Colgate’s results for 2Q’12, and underlying fundamentals showed positive signs despite a sizeable currency impact. We estimate that over 75% of Colgate’s EPS growth this quarter came from operating items (SG&A, gross margins) and share buybacks. Top-line/EBIT growth from Latin America /APAC accounted for 89% and 200% of sales/EBIT growth. While Colgate implicitly lowered "all in" EPS due to FX, you can’t really argue with 8.5% organic revenue growth in this environment."
Modi sees impressive quarters from CL, Kimberly Clark (NYSE: KMB), Unilever (NYSE: UN), Natura and L'Oreal the reverse-Procter-Gamble (NYSE: PG) Effect. However, Modi sees cheaper alternatives in the sector (vs. CL at current level).
For an analyst ratings summary and ratings history on Colgate-Palmolive Company click here. For more ratings news on Colgate-Palmolive Company click here.
Shares of Colgate-Palmolive Company closed at $106.38 yesterday, with a 52 week range of $78.62-$106.83.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Wedbush Downgrades XenoPort (XNPT) to Neutral
- Jefferies Bumps PT/Est. on AO Smith (AOS)
- Goldman Sachs Upgrades Abbott Labs (ABT) to Buy
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS View, Analyst PT ChangeRelated Entities
UBS
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
